Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $3.62 -0.32 (-8.15%) As of 09:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Eupraxia Pharmaceuticals Stock Price Performance 5 Day Performance-11.30%1 Month Performance+17.50%3 Month Performance+14.89%6 Month Performance+47.71%Year-To-Date Performance+14.16% Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address EPRX Stock Chart for Tuesday, March, 4, 2025 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/03/2025$3.98$3.94-0.88%$4.07$3.8511,427 shs$140.45 million02/28/2025$4.08$3.98-2.57%$4.13$3.8612,062 shs$141.69 million02/27/2025$4.29$4.08-4.90%$4.48$3.7741,976 shs$145.44 million02/26/2025$4.15$4.29+3.37%$4.48$4.0833,378 shs$152.92 million02/25/2025$3.76$4.15+10.37%$4.20$3.6886,132 shs$147.93 million02/24/2025$3.65$3.76+3.01%$3.88$3.6842,504 shs$134.04 million02/21/2025$3.55$3.65+2.82%$3.75$3.5356,882 shs$130.12 million02/20/2025$3.36$3.55+5.65%$3.72$3.3025,570 shs$126.56 million02/19/2025$3.33$3.36+0.90%$3.47$3.2726,106 shs$119.78 million02/18/2025$3.28$3.33+1.52%$3.44$3.2733,971 shs$118.62 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/17/2025$3.28$3.28$3.48$3.0925,795 shs$116.83 million02/14/2025$3.24$3.28+1.23%$3.48$3.0925,795 shs$116.83 million02/13/2025$3.18$3.24+1.89%$3.27$3.1515,739 shs$115.41 million02/12/2025$3.16$3.18+0.63%$3.27$3.1616,587 shs$113.27 million02/11/2025$3.14$3.16+0.60%$3.34$3.0234,396 shs$112.56 million02/10/2025$3.20$3.14-1.69%$3.33$3.1429,238 shs$111.88 million02/07/2025$3.13$3.20+2.08%$3.28$3.128,216 shs$113.82 million02/06/2025$3.07$3.13+2.12%$3.17$3.131,929 shs$111.49 million02/05/2025$3.08$3.07-0.49%$3.11$2.947,760 shs$109.18 million02/04/2025$2.98$3.08+3.36%$3.10$2.989,396 shs$109.71 million02/03/2025$2.99$2.98-0.20%$3.03$2.856,207 shs$106.16 million Related Companies Precigen Stock Chart KalVista Pharmaceuticals Stock Chart Cullinan Therapeutics Stock Chart Autolus Therapeutics Stock Chart Rapport Therapeutics Stock Chart Cartesian Therapeutics Stock Chart Entrada Therapeutics Stock Chart ABIVAX Société Anonyme Stock Chart Maze Therapeutics Stock Chart Mineralys Therapeutics Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EPRX Stock Alerts